SK
Sumit Khanduja
About Sumit Khanduja
Data last updated:
Sumit Khanduja is a Director at A2z Rental Services Private Limited (since 2022), Designated Partner at Wyzaq Healthcare Llp (since 2020) and Designated Partner at Austin Biotech Llp (since 2018). The companies operate in Internet, Healthcare and Life Sciences. The largest current company by reported revenue is A2z Rental Services Private Limited at ₹5,900 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 A2z Rental Services Private Limited U74999DL2022PTC396467 | Director | 11 Apr 2022 | 2022 | ₹5,900 (FY 2025) | Active |
| Wyzaq Healthcare Llp AAU-6094 | Designated Partner | 07 Nov 2020 | 2020 | Active | |
| Austin Biotech Llp AAM-0957 | Designated Partner | 24 Feb 2018 | 2018 | Active |
Board colleagues of Sumit Khanduja
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arjun Saroj | 08953331 | A2z Rental Services Private Limited , Wyzaq Healthcare Llp | Director |
| Deepika Goel | 08048643 | Austin Biotech Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sumit Khanduja
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sumit Khanduja
Sumit Khanduja currently holds 3 directorships: A2z Rental Services Private Limited (Director, since 11 Apr 2022, revenue ₹5,900 (FY 2025)); Wyzaq Healthcare Llp (Designated Partner, since 07 Nov 2020); Austin Biotech Llp (Designated Partner, since 24 Feb 2018).
Sumit Khanduja was first appointed on 24 Feb 2018 as Designated Partner at Austin Biotech Llp. The most recent appointment on record is 11 Apr 2022 at A2z Rental Services Private Limited.
The current boards of Sumit Khanduja's companies include Arjun Saroj (A2z Rental Services Private Limited), Deepika Goel (Austin Biotech Llp).